Abstract:We report the synthesis of 7r-substituted β-estradiol derivatives bearing side chains terminated with cholesterol and 3β-cholesterylamine. These chimeric compounds were designed to exhibit high affinity for estrogen receptors (ERs) and cellular plasma membranes to potentially enable regulated uptake of ERs by mammalian cells. Evaluation with recombinant yeast reporting compound-mediated ER dimerization revealed potencies similar to the antiestrogen ICI 182780. Compounds that efficiently deliver dominant negati… Show more
“…As reported previously, 30 cholesterol was O -alkylated to give the t -butyl acetate derivative 10 (see also 2 in Figure 7). Allylic oxidation afforded enone 11 , which was subjected to catalytic hydrogenation to give saturated ketone 12 .…”
Section: Resultsmentioning
confidence: 72%
“…30 The synthesis of Cholesterol Unit 1 was more demanding due to the need of a steroid as a starting material lacking the terminal portion of the cholesterol tail. Commercially available hyodeoxycholic acid served this purpose but required considerable modification of the functional group pattern of the A and B rings of its core in a manner similar to previous work of Zhou, et al .…”
A crosslinker was designed and synthesized as a molecular tool for potential use in probing the intracellular trafficking pathways of steroids. The design was guided by computational modeling based upon a model for the transfer of cholesterol between two proteins, NPC1 and NPC2. These proteins play critical roles in the transport of low-density lipoprotein-derived cholesterol from the lumen of lysosomes to other subcellular compartments. Two modified cholesterol residues were covalently joined by a tether based on molecular modeling of the transient interaction of NPC1 and NPC2 during the transfer of cholesterol from the binding site of one of these proteins to the other. With two cholesterol molecules appropriately connected, we hypothesize that the cholesterol binding sites of both proteins will be simultaneously occupied in a manner that will stabilize the protein-protein interaction to permit detailed structural analysis of the resulting complex. A photoaffinity label has also been introduced into one of the cholesterol cores to permit covalent attachment of one of the units into its respective protein-binding pocket. The basic design of these crosslinkers should render them useful for examining interactions of the NPC1/NPC2 pair as well as other sterol transport proteins.
“…As reported previously, 30 cholesterol was O -alkylated to give the t -butyl acetate derivative 10 (see also 2 in Figure 7). Allylic oxidation afforded enone 11 , which was subjected to catalytic hydrogenation to give saturated ketone 12 .…”
Section: Resultsmentioning
confidence: 72%
“…30 The synthesis of Cholesterol Unit 1 was more demanding due to the need of a steroid as a starting material lacking the terminal portion of the cholesterol tail. Commercially available hyodeoxycholic acid served this purpose but required considerable modification of the functional group pattern of the A and B rings of its core in a manner similar to previous work of Zhou, et al .…”
A crosslinker was designed and synthesized as a molecular tool for potential use in probing the intracellular trafficking pathways of steroids. The design was guided by computational modeling based upon a model for the transfer of cholesterol between two proteins, NPC1 and NPC2. These proteins play critical roles in the transport of low-density lipoprotein-derived cholesterol from the lumen of lysosomes to other subcellular compartments. Two modified cholesterol residues were covalently joined by a tether based on molecular modeling of the transient interaction of NPC1 and NPC2 during the transfer of cholesterol from the binding site of one of these proteins to the other. With two cholesterol molecules appropriately connected, we hypothesize that the cholesterol binding sites of both proteins will be simultaneously occupied in a manner that will stabilize the protein-protein interaction to permit detailed structural analysis of the resulting complex. A photoaffinity label has also been introduced into one of the cholesterol cores to permit covalent attachment of one of the units into its respective protein-binding pocket. The basic design of these crosslinkers should render them useful for examining interactions of the NPC1/NPC2 pair as well as other sterol transport proteins.
“…An improved two-step procedure for the 70 72 conversion was published by Tedesco et al in 1995 [33], avoiding the use of heavy metals (Scheme 5.1). This protocol was applied by Hussey et al for the synthesis of estradiol derivatives coupled to cholesterol, such as 75 [34]. A midway procedure (borate/H 2 O 2 , then PCC) was also used by Katzenellenbogen and coworkers for the introduction of a 7-mercapto or benzylthio substituent [35].…”
“…This aminosterol is a novel broad-spectrum antibiotic and exhibits a biocidal activity against Gram-positive and Gram-negative bacteria, fungi, protozoa, and viruses [15][16][17][18][19][20][21][22][23]. The antimicrobial activity of the squalamine has inspired work to design and synthesize new derivatives of steroidal-polyamine conjugates [24][25][26][27][28][29][30][31][32]. …”
Abstract:The methods of synthesis as well as physical, spectroscopic ( 1 H-NMR, 13 C-NMR, and FT-IR, ESI-MS), and biological properties of quaternary and dimeric quaternary alkylammonium conjugates of steroids are presented. The results were contrasted with theoretical calculations (PM5 methods) and potential pharmacological properties (PASS). Alkylammonium sterols exhibit a broad spectrum of antimicrobial activity comparable to squalamine.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.